A strong association has been demonstrated between candidiasis and use of IL-17 inhibitors (used in treatment of several inflammatory diseases), with significant downregulation of 9 pro-inflammatory cytokines or neutrophil-recruiting chemokines [141]. Here, IL17A is linked to candidiasis.